EverHint – Momentum Swing — Explosive Volume Breakout for Mar 11, 2026 – 5 Signals – Healthcare Leads (4)

What This Signal Is (Quick)

Explosive Volume Breakout is a momentum swing trading strategy focused on Breakouts with 2.5x+ volume surge - institutional buying pressure.

Signal Type: Breakout (momentum continuation)

What Makes This Signal:

• Stock showing strong momentum near or at highs
• Increased volume confirms institutional interest
• Breaking out or consolidating near resistance
• Breakouts with 2.5x+ volume surge - institutional buying pressure

Ideal For: Traders seeking breakouts with exceptional volume confirmation

Key Criteria:

• Strong RSI momentum (configurable thresholds)

• Volume surge above average

• Price momentum confirmation

• Minimum ADV: $25M+ (varies by variant)

• Earnings buffer: 7 days pre/post earnings

• Variant-specific filters applied

Holding Period: 1-4 weeks
Risk Level: Medium-High

How We Ranked Today

Ranked by composite momentum score (higher = stronger momentum)

📊 Momentum Swing — Explosive Volume Breakout Signals (5 Total)

Ranked by score:

Field Notes

Sector concentration: Healthcare (4), Industrials (1)

Data coverage: 0.0% insider, 0.0% congressional, 80.0% earnings, 100.0% analyst, 40.0% news

Peer Analysis

Understanding how these stocks relate to their industry peers:

RLAY (Relay Therapeutics, Inc.): Leads 9 peers: SNDX ($24.44, +1.2%), ORIC ($12.59), AMLX ($14.93, -0.3%), INBX ($73.50, +2.6%), UPB ($9.36, +15.3%) | Peer of: AMLX ($14.93, -0.3%), ATAI ($4.06, -1.9%), ELVN ($30.70, +1.5%) and 12 more

UNF (Unifirst Corporation): Leads 9 peers: ABM ($40.87, -1.0%), CBZ ($26.50, +1.8%), TNET ($36.20, -0.4%), HURN ($134.96, -0.0%), MGRC ($104.75, +0.5%) | Peer of: ABM ($40.87, -1.0%), AZZ ($125.94, -0.1%), CBZ ($26.50, +1.8%) and 6 more

SEM (Select Medical Holdings Corpora): Leads 10 peers: MD ($19.79, +0.2%), NHC ($156.34, -0.8%), ASTH ($24.19, +3.2%), ACHC ($23.89, -5.0%), USPH ($79.84, -0.2%) | Peer of: ACHC ($23.89, -5.0%), ADUS ($103.05, +0.9%), ALVO ($3.73, -3.9%) and 14 more

CGON (CG Oncology, Inc.): Leads 10 peers: CELC ($115.76, -1.1%), AAPG ($24.22, -1.1%), CNTA ($28.22, +2.3%), APGE ($74.68, -0.9%), XENE ($59.04, -2.6%) | Peer of: AAPG ($24.22, -1.1%), APGE ($74.68, -0.9%), ARQT ($23.95, -2.6%) and 11 more

DNTH (Dianthus Therapeutics, Inc.): Leads 8 peers: ELVN ($30.70, +1.5%), TSHA ($4.51, -1.2%), SANA ($3.15, -4.3%), ATAI ($4.06, -1.9%), NKTR ($73.33, +1.8%) | Peer of: ANAB ($64.67, +4.3%), ATAI ($4.06, -1.9%), ELVN ($30.70, +1.5%) and 8 more

Recent Headlines

CGON (CG Oncology, Inc.)

• CG Oncology (NASDAQ:CGON) vs. Adhera Therapeutics (OTCMKTS:ATRX) Critical Survey (source)
• CG Oncology Sees Unusually Large Options Volume (NASDAQ:CGON) (source)

UNF (Unifirst Corporation)

• Analysts Set Unifirst Corporation (NYSE:UNF) Target Price at $181.00 (source)

Market Context

Broad market indices are experiencing mild downside pressure, with the S&P 500 down 0.23%, Nasdaq off 0.26%, and Dow Jones declining 0.65%. This subtle risk-off tone suggests cautious investor sentiment, potentially curbing aggressive momentum pursuits in a momentum swing explosive volume breakout strategy. However, the VIX at 24.32—despite a 2.33% dip—remains elevated, fostering intraday swings that can amplify breakout opportunities when paired with explosive volume, though traders should brace for whipsaws in less conviction-driven setups.

Elevated volatility levels enhance the potential for sharp, volume-fueled moves ideal for this strategy, as heightened uncertainty often leads to outsized swings in leading names. Yet, the prevailing downtrend across major indices tempers overall risk appetite, favoring selective entries in resilient areas over broad market beta. With only five total signals, focus sharpens on quality over quantity amid this choppy environment.

Healthcare's prominence as the top sector hints at rotation toward defensive pockets, where momentum breakouts may thrive on relative strength even as broader markets soften. This dynamic supports the strategy's emphasis on explosive volume in outperforming groups, but demands tight risk controls given the VIX's signal of persistent choppiness and waning broad-market enthusiasm.

Vlad's Take (EverHint)

Today's signals: Strong sector concentration in Healthcare (4 signals) suggests sector-specific rotation.

Sharing Call-to-Action

🔍 If this breakdown was useful, feel free to like, share, or subscribe. Every bit of support matters.

Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

This is not financial advice. Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/